Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Seizure Induction Helps Guide Epilepsy Surgery

By HospiMedica International staff writers
Posted on 25 Jun 2019
Cortical stimulation in order to induce seizures appears to identify the epileptic generator as reliably as spontaneous seizures do, according to a new study.

Researchers at McGill University (Montreal, Canada), Grenoble-Alpes University Hospital (France), and Osaka University (Japan), analyzed data on 103 patients (52.4% female, mean age 31 years) with drug-resistant epilepsy who underwent stereoelectroencephalography (SEEG) between 2007 and 2017. More...
In all, 57.3% underwent cortical stimulation and surgical resection of the epileptogenic zone. The researchers then assessed whether removal of the epileptogenic zone was associated with a good surgical outcome.

The results showed that the percentage of patients with cortical stimulation-induced electroclinical seizures was higher in the good outcome group (70.5%) than in the poor outcome group (47.5%); the percentage of the resected contacts correlated with surgical outcome. Similar results were observed for spontaneous seizures, with 57.1% of those in the cortical stimulation-induced seizure group in the good outcome group, compared to 32.7% of those that did not undergo cortical stimulation. The study was published on June 10, 2019, in JAMA Neurology.

“This study shows we can be sure that we've found the hot spot that needs to be resected by using the stimulation, and we can get much quicker results than waiting for spontaneous seizures, which can take weeks,” said lead author Birgit Frauscher, MD, of McGill University. “Now we know that stimulation-induced seizures are very similar to spontaneous seizures, we can reduce hospital time. Instead of being in hospital for two weeks, patients can maybe be there for 48 or 72 hours, and we only need to record maybe one additional spontaneous seizure, and not several.”

First line therapy for epilepsy involves treatment with anticonvulsive drugs, and most patients will respond to one or two different medication trials. However, in up to one third of patients, medications alone will be unable to eliminate seizures, or cause unacceptable adverse effects. In such patients, work-up for the feasibility of epilepsy surgery is considered. The surgery involves a neurosurgical procedure where the focal area of the brain involved in the seizures is either resected, disconnected, or stimulated. The goal is to eliminate seizures or significantly reduce seizure burden.

Related Links:
McGill University
Grenoble-Alpes University Hospital
Osaka University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.